E. Borzenkova

Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma

I. Moiseev, A. Kozlov, K. Lepik, 2021, International Journal of Clinical Oncology.

Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine–bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma

L. Stelmakh, I. Moiseev, B. Afanasyev, 2022, International Journal of Hematology.

Treatment options for T-cell lymphomas: a single-center study

I. Moiseev, B. Afanasyev, A. Kozlov, 2020 .

TREATMENT OF RELAPSED AND REFRACTORY T‐CELL LYMPHOMAS: FIRST PAVLOV STATE MEDICAL UNIVERSITY OF SAINT‐PETERSBURG EXPERIENCE

I. Moiseev, B. Afanasyev, A. Kozlov, 2019, Hematological Oncology.